The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells

Journal of Clinical Investigation

Volumn 118, Issue 12, 2008, Pages 3917-3929

  Lu, Zhen ^a   Luo, Robert Z ^a   Lu, Yiling ^a   Zhang, Xuhui ^a   Yu, Qinghua ^a   Khare, Shilpi ^a   Kondo, Seiji ^a   Kondo, Yasuko ^a   Yu, Yinhua ^a   Mills, Gordon B ^a   Liao, Warren S L ^a   Bast Jr , Robert C ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; INTERLEUKIN 8; MAMMALIAN TARGET OF RAPAMYCIN; MATRIX PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARHI GENE; ARTICLE; AUTOPHAGY; CANCER CELL; CARCINOGENESIS; CELL SURVIVAL; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; XENOGRAFT;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIRHEUMATIC AGENTS; AUTOPHAGY; CELL LINE, TUMOR; CELL SURVIVAL; CHLOROQUINE; CYSTEINE ENDOPEPTIDASES; FEMALE; GENOMIC IMPRINTING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PHAGOSOMES; PROTEIN KINASES; RHO GTP-BINDING PROTEINS; SIROLIMUS; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

EID: 57449121645     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI35512     Document Type: Article

References (32)

1. Levine, B. 2005. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell. 120:159-162.
2. Marino, G., and Lopez-Otin, C. 2004. Autophagy: molecular mechanisms, physiological functions and relevance in human pathology. Cell. Mol. Life Sci. 61:1439-1454.
3. Shintani, T., and Klionsky, D.J. 2004. Autophagy in health and disease: a double-edged sword. Science. 306:990-995.
4. Edinger, A.L., and Thompson, C.B. 2003. Defective autophagy leads to cancer. Cancer Cell. 4:422-424.
5. Marx, J. 2006. Autophagy: is it cancer's friend or foe? Science. 312:1160-1161.
6. Jin, S., and White, E. 2007. Role of autophagy in cancer: management of metabolic stress. Autophagy. 3:28-31.
7. Kondo, Y., Kanzawa, T., Sawaya, R., and Kondo, S. 2005. The role of autophagy in cancer development and response to therapy. Nat. Rev. Cancer. 5:726-734.
8. Degenhardt, K., et al. 2006. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell. 10:51-64.
9. Carew, J.S., et al. 2007. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood. 110:313-322.
10. Arico, S., et al. 2001. The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 276:35243-35246.
11. Furuta, S., Hidaka, E., Ogata, A., Yokota, S., and Kamata, T. 2004. Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene. 23:3898-3904.
12. Qu, X., et al. 2003. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112:1809-1820.
13. Yu, Y., et al. 1999. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc. Natl. Acad. Sci. U.S.A. 96:214-219.
14. Luo, R.Z., et al. 2001. Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim. Biophys. Acta. 1519:216-222.
15. Rosen, D.G., et al. 2004. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21 WAF1/CIP1 and prolonged progression-free survival. Clin. Cancer Res. 10:6559-6566.
16. Wang, L., et al. 2003. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin. Cancer Res. 9:3660-3666.
17. Lu, Z., et al. 2006. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin. Cancer Res. 12:2404-2413.
18. Luo, R.Z., et al. 2003. ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene. 22:2897-2909.
19. Bao, J.J., et al. 2002. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res. 62:7264-7272.
20. Asanuma, K., et al. 2003. MAP-LC3 a promising autophagosomal marker, processed during the differentiation and recovery of prodocytes from PAN nephrosis. FASEB J. 17:1165-1167.
21. Kabeya, Y., et al. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
22. Takahashi, Y., et al. 2007. Bif-1 interacts with Beclin 1 through UVRAG and regulates autophagy and tumorigenesis. Nat Cell Biol. 9:1142-1151.
23. Sheehan, K., et al. 2005. Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma. Mol. Cell. Proteomics. 4:346-355.
24. Amaravadi, R.K., et al. 2007. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117:326-336.
25. Schuller, A.G., Groffen, C., van Neck, J.W., Zwarthoff, E.C., and Drop, S.L. 1994. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. Mol. Cell. Endocrinol. 104:57-66.
26. Naumov, G.N., Akslen, L.A., and Folkman, J. 2006. Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle. 5:1779-1787.
27. Semenza, G.L. 2003. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer. 3:721-732.
28. Aguirre-Ghiso, J.A. 2006. The problem of cancer dormancy: understanding the basic mechanisms and identifying therapeutic opportunities. Cell Cycle. 5:1740-1743.
29. Demicheli, R. 2001. Tumor dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol. 11:297-306.
30. Uhr, J.W., Scheuermann, R.H., Street, N.E., and Vitetta, E.S. 1997. Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med. 3:505-509.
31. Pantel, K., and von Knebel Doeberitz, M. 2000. Detection and clinical relevance of micrometastatic cancer cells. Curr. Opin. Oncol. 12:95-101.
32. Li, Y., Inoki, K., and Guan, K.L. 2004. Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol. Cell. Biol. 24:7965-7975.